A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift

The global telehealth market is experiencing significant growth, projected to expand from $77.4 billion in 2025 to $187.5 billion by 2033. Key developments include AI-powered diagnostics, remote patient monitoring, and virtual care expansion. Rocket Doctor AI joined the Altais network to expand telehealth services in California, while competitors like Teladoc Health, Amwell, Hims & Hers, and Doximity launched new AI capabilities and research initiatives to enhance digital healthcare delivery.

11/11/2026, 9:00 AM • GlobeNewswire

DOCS DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS

Rosen Law Firm has issued deadline notices for securities class action lawsuits against Doximity, Inc. and Ardelyx, Inc., with a November 16, 2026 lead plaintiff deadline. The firm is also announcing a newly filed lawsuit against NVIDIA Corporation. Investors who purchased shares during specified class periods may be eligible for compensation.

11/09/2026, 9:39 PM • GlobeNewswire

ARDX DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - ARDX

Rosen Law Firm has filed securities class action lawsuits against Ardelyx, Doximity, and NVIDIA. The primary case detailed involves Ardelyx, where investors who purchased stock between January 13, 2025 and August 6, 2026 may be entitled to compensation. The lawsuit alleges the company made materially false statements regarding commercial performance and growth prospects for its drugs XPHOZAH and IBSRELA, while concealing reimbursement barriers and prior authorization issues that hindered patient access. The lead plaintiff deadline is November 16, 2026.

11/09/2026, 9:14 PM • GlobeNewswire

Doximity: 3 Key Takeaways for Long-Term Investors

Doximity reported Q2 FY2027 revenue of $175 million with strong AI adoption across its platform. The company's AI search offering has been adopted by 16 of the top 20 pharma companies, opening access to a $14 billion digital pharma market. Quarterly active workflow prescribers grew 34% year-over-year, and the company achieved AI cost leverage through compute infrastructure optimization. Full-year revenue guidance was updated to $678-683 million.

11/09/2026, 7:51 PM • The Motley Fool

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against O-I Glass, Inc. (NYSE: OI) — Investors Who Suffered Losses Are Encouraged to Contact the Firm

Bronstein, Gewirtz & Grossman, LLC has announced multiple class action lawsuits against O-I Glass, Doximity, and UP Fintech for alleged securities fraud violations. O-I Glass investors claim the company made false statements about its Fit to Win cost-saving program and concealed operational challenges. Lead plaintiff deadlines range from November to December 2026.

11/09/2026, 1:00 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Doximity, Inc. alleging securities fraud. The complaint claims Doximity made false statements about its Newsfeed's revenue impact, overstated market position, and misrepresented advertising practices. Investors who purchased securities between August 8, 2024 and May 13, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.

11/09/2026, 1:00 PM • GlobeNewswire

DOCS FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS

Rosen Law Firm reminds investors who purchased Doximity, Inc. common stock between August 8, 2024 and May 13, 2026 of the November 16, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Doximity overstated the revenue impact of its Newsfeed feature and lost market share to competitors while relying on less effective advertising methods.

11/06/2026, 4:58 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Multiple class action lawsuits have been filed against Doximity, Webull, and UP Fintech for alleged securities fraud and violations of federal securities laws. Doximity is accused of overstating its Newsfeed's revenue impact, losing market share to competitors, and misrepresenting its advertising practices. Investors who purchased securities during specified class periods are encouraged to seek recovery.

11/05/2026, 1:00 PM • GlobeNewswire

DOCS DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS

Rosen Law Firm reminds Doximity, Inc. investors of the November 16, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Doximity overstated the revenue impact of its Newsfeed feature and lost market share to competitors while relying on less effective advertising methods. Investors who purchased stock between August 8, 2024 and May 13, 2026 may be eligible for compensation.

11/03/2026, 6:52 PM • GlobeNewswire

DOCS 截止日期：老牌律師事務所 ROSEN 鼓勵損失超過 10 萬美元的 Doximity, Inc. 投資者在對 DOCS 提出證券集體訴訟的重要截止日期前聘請律師

Rosen Law Firm is reminding investors who purchased Doximity, Inc. (NYSE: DOCS) stock between August 8, 2024 and May 13, 2026 of an important deadline of November 16, 2026 to apply as lead plaintiff in a securities class action lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth while losing market share to competitors with better pricing and engagement models.

11/01/2026, 12:54 PM • GlobeNewswire

DOCS DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DOCS

Rosen Law Firm is reminding investors in Doximity, Inc., Hims & Hers Health, Inc., and Honeywell Aerospace Inc. of upcoming deadlines to join securities class action lawsuits. Investors with losses exceeding $100K are encouraged to secure counsel before the respective deadlines. The lawsuits allege that these companies made misleading statements regarding their business performance and market position.

10/31/2026, 9:49 PM • GlobeNewswire

HIMS FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS

Rosen Law Firm is reminding investors in Hims & Hers Health, Doximity, and Honeywell Aerospace of upcoming lead plaintiff deadlines in securities class action lawsuits. The HIMS lawsuit alleges the company made false statements regarding data privacy practices and prescription charging procedures. Investors with losses exceeding $100K are encouraged to secure counsel before the November 2, 2026 deadline.

10/31/2026, 9:02 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Doximity, Inc. alleging securities fraud. The complaint claims the company made false statements about its Newsfeed's revenue impact, overstated market position, and misrepresented advertising practices. Investors who purchased Doximity securities between August 8, 2024 and May 13, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.

10/29/2026, 1:00 PM • GlobeNewswire

Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

Doximity, Inc. investors have until November 16, 2026 to seek lead plaintiff status in a securities fraud class action lawsuit. The complaint alleges the company made materially false statements and failed to disclose that it overstated its Newsfeed's revenue impact, was losing market share to competitors, and relied on less effective advertising tactics. The stock declined significantly following three negative earnings announcements between November 2025 and May 2026.

10/28/2026, 2:50 PM • GlobeNewswire

ROSEN, LEADING TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS

Rosen Law Firm is notifying investors about ongoing securities class action lawsuits against Doximity, AppLovin, and Triller Group. The firm is encouraging eligible investors who purchased shares during specified class periods to join the litigation before upcoming lead plaintiff deadlines. Doximity faces allegations of overstating Newsfeed revenue impact and losing market share.

10/28/2026, 2:47 PM • GlobeNewswire